Navigation Links
Thomson Reuters Spotlights the Impact of Personalized Medicine on Pharmaceutical R&D
Date:12/13/2012

PHILADELPHIA, Dec. 13, 2012 /PRNewswire/ -- The IP & Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the publication of a new report that provides a comprehensive view of the potential effects of personalized medicine on drug research and development. Spotlight on Personalized Medicine, a Pharma Matters report based on insights and information from Thomson Reuters Cortellis for Competitive Intelligence and a selection of data from CMR International, details the current challenges posed by the paradigm of stratified medicine as well as its clinical, economic and societal value.

"An array of scientific and market factors have prompted the pharma industry to question the sustainability of the current R&D model, which targets large populations with chronic unmet medical needs," said Jon Brett-Harris, executive vice president at Thomson Reuters. "Despite the commercial success of these products, the one-size-fits-all focus has resulted in spiraling R&D costs, longer development timelines and narrow product portfolios. New options, specifically personalized medicine, appear to be an attractive and more sustainable solution. This new report offers a detailed look into the possible advantages and disadvantages of this potentially game-changing approach."

The report shows that a stratified paradigm could result in more efficient ways of conducting drug development, as well as address increased public awareness related to post-marketing withdrawals of popular drugs and debates concerning drug pricing and reimbursement. Further, the ability to better assess bio
'/>"/>

SOURCE Thomson Reuters
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
2. Thomson Reuters Finds Increase in New Research for Neglected Tropical Diseases
3. Thomson Reuters Speeds Regulatory Decision Making with New Pharmaceutical Intelligence Solution
4. Thomson Reuters Annual Pharmaceutical Factbook Reveals Key Insights into Current Trends
5. Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences
6. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
7. Thomson Reuters Empowers Drug Development and Clinical Professionals to Develop Better, Faster Clinical Trials with Best-in-Class Intelligence Solution
8. Fujifilm Spotlights DR Expansion, Innovation At RSNA 2012
9. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
10. AdvaMed & BioOhio Discuss MedTech Impact on Ohios Economy, Job Creation
11. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 30, 2015  Astellas Pharma Inc. (TSE: 4503) today ... on the safety, tolerability and efficacy of ASP2215, a ... refractory (R/R) acute myeloid leukemia (AML) were presented during ... Clinical Oncology,s (ASCO) annual meeting in Chicago ... kinase inhibitor of FLT3 and AXL, which are involved ...
(Date:5/30/2015)... Wash. and VANCOUVER, British Columbia ... Inc. (NASDAQ: OGXI ) announced today that results ... trial showed a benefit with custirsen therapy in men ... poor prognosis. The analysis, exploring the effect of clusterin ... that over 40 percent of men in the trial ...
(Date:5/30/2015)... y SPARTANBURG , Carolina ... - Nueva colaboración para ampliar drásticamente ... con cáncer en los Estados Unidos   ... Health proporcionarán a los pacientes con cáncer apoyo ... Guardian Research Network y Molecular Health han anunciado ...
Breaking Medicine Technology:Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 2Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 2OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 4OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 5OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 6Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 2Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 3Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 4
... Masimo (NASDAQ: MASI ) announced today that ... (RRa™) was presented at the New York ... Meeting in New York City. The new ... outcomes and patient safety impact of Masimo,s unique Acoustic Respiration ...
... /PRNewswire-iReach/ -- Physicians, Capital Investments, LLC (PCI/the ... and medical investment solutions is pleased to announce ... to Dallas, TX. The new headquarters, centrally located ... Company,s real estate development, business development and administrative ...
Cached Medicine Technology:New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 2New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 3New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 4New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 5Physicians' Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX 2Physicians' Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX 3
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a new hanging ... signs ; making what was formerly an elite expensive ... points at a usual height of 16’-20’ are easily seen ... are very unique and more visible than the largest exhibits. ... labor and rigging the costs far outweigh the benefit of ...
(Date:5/29/2015)... 2015 Based in St. Louis, Missouri La ... for a couple of months now and are really ... which reads “I’m not misbehaving, I have Autism, please be ... of an autistic child in order to start a conversation ... only are they raising awareness through the autism awareness shirts ...
(Date:5/29/2015)... What does community do? , According to ... together to plant gardens, to teach young people, to ... critical issues. Community invites everyone to help improve lives ... Community Does" was commissioned by The Denver Foundation, the ... during the foundation’s Annual Celebration in May. At just ...
(Date:5/29/2015)... May 29, 2015 M3 USA MDLinx.com, ... in 14 medical specialties, now offers The Smartest ... spectrum of rheumatology disorders ranging from Fibromyalgia and Osteoporosis, ... editorial director of MDLinx, and Caroline Tredway, editorial head ... impact it will have on the physicians who participate. ...
(Date:5/29/2015)... Cincinnati, Ohio (PRWEB) May 29, 2015 ... Proven Experience to Cincinnati , The Department of Veterans ... John A. Gennaro as the new director of the ... of health care to more than 43,000 unique Veterans ... , With over 2,000 staff, CVAMC is a two-division ...
Breaking Medicine News(10 mins):Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2
... ... promotes Prize4Life. , ... (Vocus) March 24, 2010 -- In April of 2009, Director/Producer James Takata, Writers/Producers Zach ... Prize4Life’s battle against ALS. Trapped is a short film about Stephen, a talented young ...
... in Spanish . Barcelona, Spain: Recurrence ... tumour remains the strongest, independent prognostic factor for subsequent metastasis ... disease for a very long time, according to research presented ... Dr Sven Mieog, MD, a research fellow at Leiden ...
... release is available in Spanish . ... women are surviving breast cancer and delaying childbirth, it is ... fertility into consideration when deciding on treatment, the seventh European ... Dr. Anne Armstrong, from the Department of Medical Oncology, the ...
... after the death of a loved one can provide much-needed ... a study in the April issue of the Journal ... lost a relative to cancer took part in the study. ... included widows, widowers, daughters and sisters. Nine chose foot massage, ...
... Organic Relaxation Herbal ... the product works. This Herbal Tea can be purchased at Youmeandtea.com, , , ... (PRWEB) March 24, 2010 -- Organic Relaxation ... well the product works. This Herbal Tea can be purchased at Youmeandtea.com , ,"I ...
... ... obesity and empower kids to make healthy decisions. , ... (Vocus) March 24, 2010 -- To help kids to make healthy ... www.mvpkidpower.com on Facebook., , , , ,“Being on Facebook enables KidPower to actually ...
Cached Medicine News:Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 2Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 3Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 2Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 3Health News:Fertility issues in young women with breast cancer must be addressed 2Health News:Hand and feet massages provide consolation for bereaved relatives 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 3Health News:MVP Health Care Takes KidPower Youth Sports Program to Facebook 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: